Health

IASO Bio Announces NMPA Approval of IND Application for IASO-782 for Treatment of New Indication -- Systemic Lupus Erythematosus (SLE)

SHANGHAI, NANJING, China and SAN JOSE, Calif.  , July 25, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, hereby announces thatthe investigation...

2024-07-25 17:46 2006

AI for Good: Insilico Medicine Hosts IMGAIA Product Launch Event

Announcing Sustainability Benchmarking Initiative and New Gen-AI Features of Pharma.AI Platform CAMBRIDGE, Mass., July 24, 2024 /PRNewswire/ -- Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, recently hosts Insilico Medicine...

2024-07-24 21:00 1379

SoniVie announces advancements in its renal denervation program: REDUCED-1 pilot study results, radial access First-In-Human results, and FDA pivotal IDE approval of The THRIVE global study

SoniVie announces RDN pilot results, radial access FIH and FDA pivotal IDE approval, initiating the global THRIVE study in US,Europe and Israel TEL AVIV, Israel, July 24, 2024 /PRNewswire/ -- SoniVie , which has developed a novel proprietary Therapeutic Intra-Vascular Ultras...

2024-07-24 19:46 1309

Corero Network Security Announces H1 Financial Results

Company posts 16% YoY growth with increases in ARR and bookings LONDON, July 24, 2024 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQB: DDOSF), the distributed denial of service (DDoS) protection specialists, today announced its financial results for the first half of 2024. The company ...

2024-07-24 19:00 3533

IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Multiple Sclerosis

SHANGHAI, NANJING, China and SAN JOSE, Calif., July 23, 2024 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, announced that the investigational new d...

2024-07-24 09:52 1661

Origin Agritech Announces Long-Term Revenue Projections Across Key Product Lines Through 2029

BEIJING, July 23, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, is pleased to announce its revenue projections for key product lines through the year 2029. Revenue Projections Revenue from hybrid seeds a...

2024-07-23 20:00 4006

The most purchased health supplement by foreigners visiting Korea, "JungKwanJang," is now available at Sprouts Farmers Market

CERRITOS, Calif., July 23, 2024 /PRNewswire/ -- Customers can now find Korea's representative health supplement brand "JungKwanJang" at the premium market "Sprouts Farmers Market." JungKwanJang is now available at Sprouts Farmers Market! ...

2024-07-23 19:00 3854

Momcozy Launches Global Campaign to Support Diverse Breastfeeding Journeys This August

NEW YORK, July 22, 2024 /PRNewswire/ -- Global one-stop mother and baby brand Momcozy  is launching its"Breaking Barriers - Real Support for Breastfeeding Journeys" campaign

2024-07-22 22:00 1559

Lunit's AI Solution Enhances Qatar's National Breast Cancer Screening Program

* Middle East's first full-scale AI adoption for national screening marks Lunit's latest milestone amid rapid expansion of global cancer screening initiatives SEOUL, South Korea, July 22, 2024 /PRNewswire/ -- Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeut...

2024-07-22 21:00 2172

QingSong Health and Globethics Announce Strategic Partnership

BEIJING, July 21, 2024 /PRNewswire/ -- QingSong Health, a leading health technology platform based inChina, has announced a strategic partnership with Globethics,en international leading organization on ethical leadership based in Geneva, Switzerland. This collaboration is set to push forward the...

2024-07-22 11:49 1385

Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors

HEIDELBERG, Germany and GEMBLOUX, Belgium and SHANGHAI, China, July 21, 2024 /PRNewswire/ -- Full-Life Technologies, a fully integrated global radiotherapeutics company, today announcedthe appointment of Ted Myles to Full-Life's Board of Directors. Mr. Myles will serve as chairman of the audit c...

2024-07-22 08:00 1227

Treatment of Type 2 diabetes with Chiglitazar combined with Metformin Approved for listing by the National Medical Products Administration

SHENZHEN, China, July 19, 2024 /PRNewswire/ -- On July 19, Shenzhen Chipscreen Biosciences Co., Ltd. (hereinafter referred to as "Chipscreen Biosciences") announced that it has received the Drug Registration Certificate approved and issued by the National Medical Products Administration (NMPA) fo...

2024-07-19 22:01 4747

111 Announces Appointment of New Auditor

SHANGHAI, July 19, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream inChina, today announced  the appointment o...

2024-07-19 20:45 2995

Harbour BioMed Announces Positive Profit Alert for 2024 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, July 18, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

2024-07-19 07:15 2758

VARON Enters CPAP and BiPAP Machine Market with Feature-Rich "Sunny Grand" Series

SEATTLE, July 18, 2024 /PRNewswire/ -- VARON , a leading provider of oxygen concentrator solutions, is thrilled to announce the launch of its new line ofCPAP (continuous positive airway pressure)

2024-07-19 01:30 1289

Ubie and the American Kidney Fund Collaborate to Speed Early Diagnosis and Education for Kidney Disease

* Kidney disease kills more Americans every year than breast or prostate cancer, but 9 in 10 don't know they have the disease, leading to late diagnosis and irreversible damage * The collaboration will fine tune Ubie's Symptom Checker AI with the goal of accelerating time to diagnosis for pat...

2024-07-19 00:00 1488

ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development

NEWARK, Del., July 18, 2024 /PRNewswire/ -- At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting inHamburg, ACROBiosystems announced its new GMP-centered brand, Resilient Supply, with the mission of accelerating the advancement of cell and gene therapy (CGT) developme...

2024-07-19 00:00 2179

Assessment of supply chain risk key to improving medicine access

A four-year research project by INSEAD and five other institutions sheds light on how understandingmedical criticality, supply chain risk and their interactions could help us better address drug shortages. FONTAINEBLEAU, France, SINGAPORE and SAN FRANCISCO, July 18, 2024 /PRNewswire/ -- Drug s...

2024-07-18 23:00 2072

Samyang Corp Showcases Specialty Ingredients at World's Largest Food Technology Expo

* Participates in the IFT 2024 International Food Technology Expo held in Chicago, USA from July 15-17 * Focuses on promoting alternative sweetener Allulose and soluble dietary fiber Resistant dextrin * Displays tasting samples and actual products incorporating specialty ingredients to a...

2024-07-18 20:30 2174

Duoning showcases its comprehensive bioprocess solutions at Interphex Korea 2024

SHANGHAI, July 18, 2024 /PRNewswire/ -- Duoning Biotechnology Group ("Duoning"), a leading one-stop bioprocess solution provider, announced it has attended at Interphex Korea 2024 to showcase its total bioprocess solutions for the preparation of diverse biological products. Interphex 2024 provide...

2024-07-18 20:00 1897
1 ... 9101112131415 ... 273

Week's Top Stories